Health Professional Radio - Podcast

Dr. John Albert, a rheumatologist at the Rheumatic Disease Center in southeastern Wisconsin, discusses a Horizon Therapeutics presentation from the American College of Rheumatology (ACR) Annual Meeting 2019 that looked at how methotrexate may attenuate the immune response to KRYSTEXXA to allow more patients on KRYSTEXXA to continue their treatment and is helping to inform rheumatologists on effective treatment practices to control this serious and chronic disease of gout.